Article type
Year
Abstract
Background:
Equity is defined as the absence of avoidable differences in health outcomes. Average results may obscure differences in outcomes across specific populations who may experience health inequity. Systematic reviews can explore the robustness of findings across specific populations who may experience health inequity.
Objectives:
1) Participants will understand how to incorporate equity considerations into their systematic reviews.
2) Participants will understand how to report equity considerations completely and transparently.
Description:
Participants will be introduced to the mnemonic PROGRESS-Plus and how it can be used to formulate questions and design methods to consider health equity (PROGRESS-Plus: Place of residence, Race/ethnicity/language/culture/language, Occupation, Gender/sex, Religion, Education, Socioeconomic status, Social capital).
We will introduce participants to guidance for reporting equity-focussed reviews (PRISMA Equity 2012) and the 2017 GRADE working group guidance on considering health equity in guideline development. We will discuss how stakeholder engagement and inclusion of patients is congruent with health equity goals in reviews and guidelines.
Participants will be divided into small groups to discuss hot topics in the consideration of health equity in Cochrane systematic reviews.
Equity is defined as the absence of avoidable differences in health outcomes. Average results may obscure differences in outcomes across specific populations who may experience health inequity. Systematic reviews can explore the robustness of findings across specific populations who may experience health inequity.
Objectives:
1) Participants will understand how to incorporate equity considerations into their systematic reviews.
2) Participants will understand how to report equity considerations completely and transparently.
Description:
Participants will be introduced to the mnemonic PROGRESS-Plus and how it can be used to formulate questions and design methods to consider health equity (PROGRESS-Plus: Place of residence, Race/ethnicity/language/culture/language, Occupation, Gender/sex, Religion, Education, Socioeconomic status, Social capital).
We will introduce participants to guidance for reporting equity-focussed reviews (PRISMA Equity 2012) and the 2017 GRADE working group guidance on considering health equity in guideline development. We will discuss how stakeholder engagement and inclusion of patients is congruent with health equity goals in reviews and guidelines.
Participants will be divided into small groups to discuss hot topics in the consideration of health equity in Cochrane systematic reviews.